The Effect Of Beta-Lactam-Containing Drugs On The Development Of Drug Allergy, 14-24
Making Antibiotic-Resistant E. coli Non-Resistant with CRISPR/Cas9 Gene Editing, 25-30
Chaperonin Variants in The Genus Acetobacter impacts Resistance To The Heat-Shock Stress, 31-27
Fanzor: A Promising CRISPR-like Gene Editing Tool in Eukaryotes, 38-42
Gene editing tools and the treatment of cystic fibrosis disease, 1-8
Gene Therapy Products Approved in 2022, 9-13
The CRISPR-Cas12 SHERLOCK System Can Identify HIV, 14-18
Expression of Axolotl P53 Gene May Increase Cancer Resistance, 30-34
Gene Therapy Products Reached to Market by 2021, 1-21
Development of Gene Editing Strategies for CCR5 Gene in Endothelial Cells, 22-30
Diagnosis and Treatment of Fanconi Anemia: Special Focus on Nuclease-Mediated Gene Therapy, 31-35
The Development of Recombinant hSpCas9 Production System in E. coli, 36-43
2020
The use of CRISPR/Cas9 gene editing system in the treatment of HBV infection, 1-7
Gene editing studies for the treatment of AIDS, 8-20
Gene editing studies for the treatment of anemia, 21-29
Alternative Therapy to Antibiotics: CRISPR-Cas antimicrobials, 30-35